Fulgent Genetics (FLGT) Live Share Price, Invest From India

Fulgent Genetics Stock Performance

as on August 26, 2026 at 2:16 pm IST

Day's Low
Day's High
$19.35
Day's Price Range
$20.05
$19.95
3.01%
Downside
0.50%
Upside
52 Week's Low
52 Week's High
$13.46
52-Week Price Range
$31.04
$19.95
32.53%
Downside
55.59%
Upside

Fulgent Genetics share price movements today

Previous Close: $19.45
Open: $19.52
Volume: 315.5K
Market Cap: $510.7M
Day's Low - High: $19.35 - $20.05
52 Week Low - High: $13.46 - $31.04

Fulgent Genetics Historical Returns

1 Month Return: -7.94 %
3 Month Return: + 18.22 %
1 Year Return: -12.7 %
3 Year Return: -45.9 %
5 Year Return: -79.96 %

Fulgent Genetics Stock Fundamentals & Key Indicators

Check Fulgent Genetics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$510.7M

EPS (TTM)

-2.82

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.99%

PE Ratio (TTM)

-6.61

Industry PE ratio

-14.145

PEG Ratio

0.11683909276209503

EBITDA

-65.0M

Revenue (TTM)

323.9M

Profit Margin

35.58%

Return On Equity TTM

-7.87%

Fulgent Genetics Stock Valuation

Track how Fulgent Genetics P/E has moved over time to understand its valuation trends.

Fulgent Genetics in the last 5 years

Overview
Trends

Lowest (-13.34x)

December 31, 2025

Industry (-14.14x)

December 31, 2025

Today (-13.34x)

December 31, 2025

Highest (6.25x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -13.34x

Fulgent Genetics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fulgent Genetics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Fulgent Genetics	BUY	$510.7M	-79.96%	-6.61	35.58%	NA
Natera	BUY	$44.7B	209.4%	-228.51	65.30%	NA
Agilent	BUY	$41.9B	-7.69%	29.83	19.55%	54.75%
Thermo Fisher	BUY	$217.5B	5.75%	32	40.37%	0.3%
Danaher	BUY	$142.3B	-36.92%	36.11	58.51%	0.7100000000000001%

Stock Returns calculator for Fulgent Genetics Stock including INR - Dollar returns

The Fulgent Genetics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Fulgent Genetics investment value today

Current value as on today

₹1,02,194

Returns

₹2,194

(+2.19%)

Returns from Fulgent Genetics Stock

-₹6,162 (-6.16%)

Dollar Impact

₹8,356 (+8.36%)

Analyst Recommendation on Fulgent Genetics Stock

Based on 1 analysts

BUY

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Fulgent Genetics. Average target price of $19

Fulgent Genetics Share Price Target

Get share price movements and forecasts by analysts on Fulgent Genetics.

What analysts predicted

-5%DOWNSIDE

Target Price

$19

Current Price

$19.95

Analyzed by

1 Analysts

Target

$19.00

Fulgent Genetics target price $19, a slight downside of -5% compared to current price of $19.95. According to 1 analysts rating.

Indian Investors' Interest in Fulgent Genetics Stock

Search interest for Fulgent Genetics Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 27, 2026 to August 26, 2026

Change:-67% versus previous 30 day period

Fulgent Genetics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	64	71	71	76	73	81	84	83	71	85
Gross Profit	22	26	26	31	28	34	35	32	21	25
Operating Income	-21	-18	-17	-16	-19	-19	-15	-36	-34	-33
EBITDA	-7	-5	-12	-1	-5	-15	0	-23	-19	-21
Interest Expense	-	-	0	0	0	0	0	0	0	0
Depreciation	6	6	5	6	5	6	6	6	6	7
Income Before Tax	-14	-11	-18	-8	-11	-21	-6	-29	-25	-29
Income Tax Expense	0	-2	-3	-1	0	-2	0	-5	0	0
Net Income	-13	-8	-14	-5	-11	-18	-6	-23	-24	-29
Net Profit Margin	34.28%	37.30%	37.32%	41.79%	38.59%	42.10%	42.24%	39.10%	30.21%	30.07%

Fulgent Genetics Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	18	21	32	421	992	618	289	283	322
Gross Profit	10	10	18	331	777	366	104	107	130
Operating Income	-3	-5	0	290	675	178	-195	-73	-91
EBITDA	-1	-2	1	293	692	217	-147	-26	-45
Interest Expense	-	-	-	-	-	1	0	0	0
Depreciation	1	2	2	2	11	32	26	24	24
Income Before Tax	-3	-4	0	286	681	184	-174	-51	-70
Income Tax Expense	-1	0	0	72	174	42	1	-8	-8
Net Income	-2	-5	0	214	507	143	-167	-42	-60
Net Profit Margin	54.35%	49.94%	56.63%	78.70%	78.29%	59.28%	36.12%	37.82%	40.56%

Fulgent Genetics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-13	-9	-14	-6	-11	-19	-6	-23	-24	-30
Operating Cash Flow	7	4	-15	25	-4	-30	11	-78	7	-23
Investing Cash Flow	-47	7	8	-27	27	53	19	11	10	50
Financing Cash Flow	-2	-1	0	0	-11	-2	0	0	-44	-24
Change in Cash	-42	10	-6	-2	12	20	29	-67	-26	2

Fulgent Genetics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-2	-5	0	214	506	141	-167	-43	-61
Operating Cash Flow	1	0	5	140	538	253	27	21	-101
Investing Cash Flow	-2	0	-29	-326	-546	-261	38	-58	111
Financing Cash Flow	0	0	28	261	85	-77	-47	-4	-14
Change in Cash	-1	0	5	75	77	-85	17	-42	-4

Mutual Funds that own Fulgent Genetics Stock

Check out the Mutual Funds with significant holdings in Fulgent Genetics.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	3.115187%	857153
NORTHERN LIGHTS FUND TRUST II	1.687221%	464244
COLUMBIA FUNDS SERIES TRUST I	1.353352%	372379
Columbia Funds Series Trust I	1.261403%	347079
DFA INVESTMENT DIMENSIONS GROUP INC	1.16244%	319849

See all

Global Institutional Holdings in Fulgent Genetics

Funds	Holdings
ALPS	0.12%
Avantis	0.12%
Vanguard	3.49%
iShares	3.12%
Dimensional	0.95%

See all

Insights on Fulgent Genetics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, FLGT stock has moved up by 12.9%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 71.13M → 85.38M (in $), with an average increase of 16.7% per quarter
NO EFFECT
Against Peers
In the last 1 year, Natera, Inc. Common Stock has given 103.2% return, outperforming this stock by 110.3%
NO EFFECT
Against Peers
In the last 3 years, Natera, Inc. Common Stock has given 486.8% return, outperforming this stock by 527.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, -6.60M → -29.53M (in $), with an average decrease of 93.1% per quarter

About Fulgent Genetics

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, large corporations, and patients. Fulgent Genetics, Inc. was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.

Organisation	Fulgent Genetics
Headquarters	4399 Santa Anita Avenue, El Monte, CA, United States, 91731
Industry	Diagnostics & Research
CEO	Mr. Ming Hsieh
E-voting on shares	Click here to vote

Key Management of Fulgent Genetics

Name	Title
Mr. Ming Hsieh	Chairman & CEO
Mr. Paul Kim CPA	Chief Financial Officer
Dr. Hanlin Gao D.A.B.M.G., FACMG, M.D., Ph.D.	Chief Scientific Officer & Lab Director
Ms. Natalie Prescott CIPM, CIPP	General Counsel & Chief Privacy Officer
Ms. Ellen Tsui	Vice President of Human Resources
Mr. Brandon Perthuis	Chief Commercial Officer
Mr. Jian Xie	COO & President
Ms. Doreen Ng	Vice President of Operations & Compliance
Mr. Jakub Sram	Vice President of Business Development & Sales
Mr. Elias Nyankojo	Chief Information Security Officer

FAQs

What is Fulgent Genetics share price today?

Fulgent Genetics share price today is $19.95 as on August 26, 2026 at 8:46 am IST at the close of the market. Fulgent Genetics share today touched a day high of $20.05 and a low of $19.35.

What is the 52 week high and 52 week low for Fulgent Genetics share?

Fulgent Genetics share touched a 52 week high of $31.04 on November 25, 2025 and a 52 week low of $13.46 on March 3, 2026. Fulgent Genetics stock price today i.e. August 26, 2026 at 8:46 am IST is closed at $19.95,which is 35.73% down from its 52 week high and 48.22% up from its 52 week low.

What is Fulgent Genetics's market capitalisation today?

Fulgent Genetics market capitalisation is $0.00T as on August 26, 2026 at 8:46 am IST.

How to invest in Fulgent Genetics Stock (FLGT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Fulgent Genetics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Fulgent Genetics Shares that will get you 0.0752 shares as per Fulgent Genetics share price of $19.95 per share as on August 26, 2026 at 8:46 am IST.

What is the minimum amount required to buy Fulgent Genetics Stock (FLGT) from India?

Indian investors can start investing in Fulgent Genetics (FLGT) shares with as little as ₹95.41 or $1 (as of August 26, 2026 at 11:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹954.10 in Fulgent Genetics stock (as per the Rupee-Dollar exchange rate as on August 26, 2026 at 11:38 am IST). Based on Fulgent Genetics share’s latest price of $19.95 as on August 26, 2026 at 8:46 am IST, you will get 0.5013 shares of Fulgent Genetics. Learn more about fractional shares .

What are the returns that Fulgent Genetics has given to Indian investors in the last 5 years?

Fulgent Genetics stock has given -79.96% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?